Due to its insulinotropic action (stimulates insulin secretion), GLP-1-based treatments effectively prevent postprandial hyperglycemia (post-meal glucose spikes) in patients with T2DM
A Gallup poll showed that around 15.5 million Americans reported using Ozempic or similar medicines to lose weight
It is estimated that 43% of the non-diabetic adult US population in 2025 is obese
Side Effects: What are the possible side effects of Compounded GLP-1s: Compounded GLP-1s may cause serious side effects, including: Stomach problems: Commonly patients experience diarrhea, nausea, and vomiting, These side effects may may cause a loss of fluids (dehydration) which may cause kidney problems
Researchers in BMJ reviewed almost 10,000 reports of the use of weight loss medications or behavioral programs, and identified 37 studies with low risk of bias (with 9,431 participants) on which to perform a meta-analysis